FdaApplication
ANDA 077221
Identifiers
- fda_app_no: ANDA077221
Properties
| Property | Value |
|---|---|
| applicant_name | CIPLA LTD |
| application_type | ANDA |
| approval_date | 2017-03-03 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LAMIVUDINE | LAMIVUDINE | 150MG | TABLET;ORAL |
| LAMIVUDINE | LAMIVUDINE | 300MG | TABLET;ORAL |
2 products